Catch a candid discussion with Bioclinica experts as they discuss clinical trials and ways to simplify the clinical development process in a recent episode of Worldwide Business with Kathy Ireland®!
Each week the Fox Business Network sponsored program explores the real-world insights of corporate executives from around the globe.
In this episode, the conversation kicks off with Bioclinica CEO John Hubbard and President of eHealth Solutions Mukhtar Ahmed examining complexities in clinical trials - and more importantly - how we bring clarity to the clinical development process.
Also featured are expert viewpoints from across all three business segments making up our multi-faceted organization: Global Clinical Research, Imaging & Biomarkers, and eHealth Solutions.
The discussion explores new thinking and approaches surrounding big data and analytics, technology, biomarkers, patient recruitment and retention, supply chain, Alzheimer's research, personalized medicine, and more.
Tune in and find out how Bioclinica is transforming the way clinical research is conducted.
John Hubbard and Mukhtar Ahmed talk about ways Bioclinica is streamlining the clinical development process. This sponsored programming originally aired on the Fox Business Network on April 3, 2016.
Discover all the hot topics in the Bioclinica blog!
In upcoming posts we will dissect key program topics and get additional insights from John and Mukhtar as well as other Bioclinica experts, including:
Kristina Zakrzewski, Director, Randomization & Trial Supply Management (RTSM) for eClinical Solutions discusses our end-to-end RTSM solution, bringing visibility as participants move through the clinical trial process. The technology ensures the right drug supply is in the right place at the right time despite variables within a complex supply chain and regulatory environment. Kristina also talks about our collaborative embedded RTSM model for the utmost results and effective management of drug supply in clinical trials.
Andrew Masters, SVP, Product Development & Technology for eHealth Solutions tells how our eHealth Cloud is creating opportunities to integrate and share data, allowing niche technologies to enter within the regulated environment. Doors are opening to innovation! Find out how all members of the research community can benefit.
David Herron, President, Medical Imaging & Biomarkers, speaks to our extensive Medical Imaging trial expertise, noting our well-rounded scientific, operational and technical teams provide high quality evaluation and interpretation of medical images, supporting the advancement of clinical research.
Joyce Suhy, PhD, Vice President & Head of Neuroscience, Medical Imaging, describes our work in Alzheimer's disease, which in the past 10 years alone totals over 100 trials, tens of thousands of patients and hundreds of thousands of MRI and PET scans. She discusses exciting opportunities, particularly in prevention and diagnosis, and Bioclinica's commitment to the field of Alzheimer's research.
Elizabeth Thiele, President, Global Clinical Research, sheds light on digital approaches to connect the right patients with the right clinical trials and patient-centered engagement. She also discusses exciting advancements that can further Alzheimer's research and a targeted new approach to successful post-approval research.
Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.